نتایج جستجو برای: tumor peptide

تعداد نتایج: 576890  

Journal: :iranian journal of radiation research 0
s.p. shirmardi 1 nuclear engineering and physics, amirkabir university of technology, tehran, iran m. shamsaei 1 nuclear engineering and physics, amirkabir university of technology, tehran, iran m. gandomkar nuclear science research school, nuclear sciences and technology research institute, tehran, iran m. ghannadi maragheh nuclear fuel cycle research school, nuclear sciences and technology research institute, tehran, iran

background: chlorotoxin is a 36-amino acid peptide found in the venom of the leiurus quinquestriatus which blocks small-conductance chloride channels. chlorotoxin binds preferentially to glioma cells that allow development of new methods for the treatment and diagnosis of several types of cancer. thus chlorotoxin derivative was labeled with 131i for further investigation. materials and methods:...

Journal: :iranian journal of nuclear medicine 2011
seyed pezhman shirmardi mostafa erfani mohammad mazidi

introduction: bombesin is a 14-aminoacid peptide isolated from frog skin. the mammalian counterparts of the frog peptide are neuromedin b (nmb) and gastrin-releasing peptide (grp). bombesin (bbn) is a peptide showing high affinity for the gastrin releasing peptide receptor (grpr). prostate, small cell lung cancer, breast, gastric, and colon cancers are known to over express receptors to bombesi...

Journal: :Materials advances 2021

Combination of RGD cell adhesion peptide with GHK modulator synergistically improves targeting tumor cells. Amphiphilic peptides can be effectively displayed on liposomal surface for screening and drug delivery applications.

Mohammad Mazidi Mostafa Erfani, Seyed Pezhman Shirmardi

  Introduction: Bombesin is a 14-aminoacid peptide isolated from frog skin. The mammalian counterparts of the frog peptide are neuromedin B (NMB) and gastrin-releasing peptide (GRP). Bombesin (BBN) is a peptide showing high affinity for the gastrin releasing peptide receptor (GRPr). Prostate, small cell lung cancer, breast, gastric, and colon cancers are known to over...

Journal: :Anticancer Research 2021

Background/Aim: We have tested whether the anticancer peptide, PNC-27, that kills cancer cells but not normal by binding to cell membrane HDM-2 forming pores, CD44+ colon stem cells. Materials and Methods: Flow cytometry determined CD44 expression on six-colon lines one line (CCD-18Co). MTT, LDH release, annexin V caspase 3 assays were used assess PNC-27-induced death. Bioluminescence imaging m...

ژورنال: Medical Laboratory Journal 2015
Haghighatfard, H, Yazdani, Y., Y,

Abstract Background and Objective: the inhibition of tumor-associated angiogenesis can significantly reduce the tumor proliferation. The basic fibroblast growth factor (bFGF), an important angiogenic factor, is considered as a potential therapeutic target for cancer therapy. The purpose of this study was evaluating, designing and construction of new recombinant DNA molecule in order to ha...

Journal: :Scholarly Research Exchange 2009

Journal: :Journal of Immunology 2023

Abstract Vaccination with tumor epitopes associated MHC-I is an attractive approach directed at inducing tumor-specific CTLs. However, challenges remain in improving the therapeutic efficacy of peptide epitope vaccines, including low immunogenicity and insufficient stimulation innate immune components vivo. Herein, we report innovative strategy to overcome limitations. The essential feature thi...

Journal: :International Journal of Biological Macromolecules 2021

Epitope peptides are not suitable for nasal administration immunity due to their poor immunogenicity and low delivery efficiency. Here, we reported an intranasal self-assembled nanovaccine (I-OVA NE), which was loaded with the IKVAV-OVA257–264 (I-OVA), a laminin peptide (Ile-Lys-Val-ala-Val, IKVAV) OVA257–264 epitope conjugated peptide. This I-OVA at concentration of 4 mg/mL showed average part...

Journal: :International journal of cancer and clinical research 2021

AMD3100 (Plerixafor), a specific antagonist of CXCR4, is the most potent small molecule non-peptide inhibitor to CXCR4/CXCL12 axis. The chemokine receptor CXCR4 and its ligand CXCL12 (SDF-1) expressed in variety tumor cells play an important role regulating biological behavior. microenvironment (TME) environment around tumor, comprising blood vessels, immune cells, fibroblasts, signaling molecu...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید